Production (Stage)
AEON Biopharma, Inc.
AEON
$0.534
-$0.015-2.73%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 134.87% | 110.92% | 103.48% | -291.59% | -630.23% |
| Total Depreciation and Amortization | -8.08% | -2.02% | -8.41% | 7.53% | 21.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -141.47% | -118.59% | -111.75% | 751.71% | 1,849.35% |
| Change in Net Operating Assets | -63.42% | 125.78% | -217.21% | -266.90% | -171.47% |
| Cash from Operations | 56.79% | 57.57% | 32.19% | -5.52% | -16.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -23.08% | 7.14% | 7.14% | -67.74% | -70.79% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 119.18% | 8.19% | 50.38% | -64.71% | -67.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 127.46% | 84.79% | 55.65% | -2,582.34% | -2,421.05% |